-
IntroducedFeb 19, 2020
-
Passed Senate
-
Passed House
-
Signed into Law
AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS. To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.
Last Action See all actions
Senate • Mar 11, 2020: Filed with Legislative Commissioners' Office
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on SB 138
Tweets
Whip Lists
Sponsors
- General Law Committee
Votes
YES: 12
- D'Agostino M.
- Maroney J.
- Leone C.
- Gibson B.
- McCrory D.
- Fonfara J.
- Allie-Brennan R.
- Altobello E.
- Arconti D.
- Candelaria J.
- Luxenberg G.
- Riley E.
NO: 6
- Witkos K.
- Cheeseman H.
- Kissel J.
- Ackert T.
- Candelora V.
- Rutigliano D.
ABSENT: 1
- D'Amelio A.
Actions
- Mar 11, 2020 | Senate
- Filed with Legislative Commissioners' Office
- Mar 10, 2020 | Senate
- Joint Favorable
- Feb 21, 2020 | Senate
- Public Hearing 02/27
- Feb 19, 2020 | Senate
- Referred to Joint Committee on General Law
Bill Texts
Documents